Pharmaco - Press Releases

Date	Title	Company
24-Feb-2021	Takeda Provides Updates on Phase 1/2 Clinical Trials of Novavax’ and Moderna’s COVID-19 Vaccine Candidates in Japan	Takeda
24-Feb-2021	Fresenius Medical Care AG & Co. KGaA published form 20-F for the fiscal year 2020	Fresenius Medical Care AG & Co. KGaA
24-Feb-2021	XPhyto Therapeutics Corp.: XPhyto Places First Order for 25-Minute Covid-19 RT-PCR Tests	XPhyto Therapeutics Corp.
24-Feb-2021	Formycon receives positive Scientific Advice from Paul-Ehrlich-Institute for the COVID-19 Drug FYB207 and assures GMP Manufacturing Capacities	Formycon AG
24-Feb-2021	Relief Reports: NeuroRx Announced that RLF-100(TM) has Demonstrated Ten-Day Accelerated Recovery from Respiratory Failure among Patients with Severe Covid-19 Treated with HFNO at 28 Day Interim Endpoint	RELIEF THERAPEUTICS Holdings AG
23-Feb-2021	Registration is open for SMi’s 4th Annual Pharmaceutical Microbiology West Coast 2021	SMi Group
23-Feb-2021	DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand	DNA Script
23-Feb-2021	Almac Group Completes £5million Research & Development Centre	Almac Group
23-Feb-2021	FDA Approves Libtayo® as Monotherapy for Advanced NSCLC	Sanofi
23-Feb-2021	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference	Pfizer
23-Feb-2021	Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate	Sanofi
23-Feb-2021	Sanofi to provide manufacturing support to Johnson & Johnson for their COVID-19 vaccine to help address global supply demands	Sanofi
23-Feb-2021	NovalGen enters strategic partnership with HALIX B.V. to manufacture clinical trial materials	NovalGen
23-Feb-2021	Anthony Nolan Cell & Gene Therapy Services and ONK Therapeutics Announce Collaboration	ONK Therapeutics
23-Feb-2021	MaxiVAX and Minaris Regenerative Medicine Enter into a Manufacturing Partnership for MVX-ONCO-2 Cancer Immunotherapy	MaxiVAX and Minaris Regenerative Medicine
23-Feb-2021	SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines.	SB3000 ApS
23-Feb-2021	Novo Holdings to acquire Altasciences	Novo Holdings
23-Feb-2021	FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%	Sanofi
23-Feb-2021	OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated Peptide Analogues for treating Ocular Pain and Inflammation	OKYO Pharma
23-Feb-2021	Solentim expands global reach, opening new operation in China	Sciad Newswire